High beta stocks, shares with relatively high levels of return volatility, are leading the field by a wide margin, based on a set of ETFs.

PharmaEssentia Corporation develops and distributes drugs to treat hepatitis, chronic myeloid leukemia, essential thrombocythemia, myeloid fibrosis, polycythemia vera, hepatitis, and cancer.